NIPH
NKTR icon

NN Investment Partners Holdings’s Nektar Therapeutics NKTR Stock Holding History

NN Investment Partners Holdings’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-146
Closed -$72K – 780
2018
Q4 		$72K Sell
146
-1,389
-90% -$838K ﹤0.01% 695
2018
Q3 		$1.4M Buy
+1,535
New +$1.31M 0.01% 506

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

NN Investment Partners Holdings's NKTR Position: Q1 2019 in Review

NN Investment Partners Holdings sold out of Nektar Therapeutics (NKTR) in Q1 2019, closing a stake of 146 shares — an estimated $72K sold.

NN Investment Partners Holdings first reported a position in NKTR in Q3 2018 and held it in 2 quarters. The position peaked at $1.4M in Q3 2018. 350 funds tracked by Wall St. Rank hold NKTR as of Q1 2019.

  • NN Investment Partners Holdings reported no remaining Nektar Therapeutics position as of Q1 2019 after selling out during the quarter.
  • NN Investment Partners Holdings sold 146 Nektar Therapeutics shares in Q1 2019, an estimated $72K.
  • NN Investment Partners Holdings first reported a position in Nektar Therapeutics in Q3 2018 and held it in 2 quarters.
  • NN Investment Partners Holdings's Nektar Therapeutics position peaked at $1.4M in Q3 2018.
  • 350 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2019.

Based on NN Investment Partners Holdings's 13F filing for Q1 2019, filed 14 May 2019.